PUOTI, MASSIMO

PUOTI, MASSIMO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 346 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autori File
A Randomized Clinical Trial to Compare Moxifloxacin Versus Azithromycin for the Treatment of Mycoplasma genitalium: The FARTHEST Study 01 - Articolo su rivista 2026 Bernasconi D. P.Puoti M. +
A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C 01 - Articolo su rivista 2026 Puoti M. +
Absence of Pharmacodynamic Interference Following Concomitant Administration of Long-Acting Cabotegravir/Rilpivirine and Intramuscular Antibiotics for Sexually Transmitted Infections in People with HIV 01 - Articolo su rivista 2026 Cavazza G.Puoti M. +
AISF-SIMIT practice guidance on treatment of hepatitis d virus (HDV): A 2025 update 01 - Articolo su rivista 2026 Puoti M. +
Antimicrobial Stewardship (AMS) program in Lombardy region: analysis of effectiveness and costs 02 - Intervento a convegno 2026 Bonfanti PPuoti M +
Community-Acquired Pneumonia Outside the Intensive Care Unit: Clinical Characteristics and Impact of Rapid Molecular Diagnostics in the Italian SIS-NET Study 01 - Articolo su rivista 2026 Puoti, MassimoCocuzza, ClementinaRusso, Alessandro +
Correspondence: the recommended resistance-guided treatment of Mycoplasma genitalium infection in symptomatic individuals is not feasible in many Italian settings 01 - Articolo su rivista 2026 Puoti M. +
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis? 01 - Articolo su rivista 2026 Lapadula G.Puoti M.Russo D.Bonfanti P. +
Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir–Velpatasvir 01 - Articolo su rivista 2026 Puoti M. +
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: Real-world data from the PRESTIGIO Registry 01 - Articolo su rivista 2026 Puoti M. +
Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program 01 - Articolo su rivista 2026 Puoti M. +
Empirical piperacillin/tazobactam vs carbapenems to treat bloodstream infections due to ESBL enterobacterales: a propensity score-matched observational study conducted in an emergency department in Northern Italy 01 - Articolo su rivista 2026 Rossmann M.Scarnera M.Bernasconi D. P.Puoti M.Bombelli M. +
High Baseline Prevalence and Stable Incidence of Chlamydia and Gonorrhea During the First Year of HIV Pre-Exposure Prophylaxis: A Multicenter Italian Cohort Study 01 - Articolo su rivista 2026 Puoti M. +
HIV breakthrough infection after 6 years of daily TDF/FTC oral PrEP with objectively documented optimal adherence 01 - Articolo su rivista 2026 Puoti M. +
Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres 01 - Articolo su rivista 2026 Puoti M.Lapadula G.Bonfanti P. +
In-hospital antibiotic consumption in Lombardy, Italy (2017-2024): a retrospective analysis of regional administrative data 01 - Articolo su rivista 2026 Puoti M. +
MRI‑based scoring system to predict spondylodiscitis: The SPONDY-Score 01 - Articolo su rivista 2026 Puoti M. +
Non-occupational post-exposure prophylaxis does not expand or differentiate candidates for pre-exposure prophylaxis 01 - Articolo su rivista 2026 Puoti M. +
Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV 01 - Articolo su rivista 2026 Lapadula G.Puoti M.Bonfanti P. +
Patterns and Correlates of Initiation of Long-Acting Injectable Cabotegravir for Preexposure Prophylaxis: A Case-Control Analysis 01 - Articolo su rivista 2026 Puoti M. +